Rankings
▼
Calendar
LUNG Q4 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$24M
+23.3% YoY
Gross Profit
$18M
74.0% margin
Operating Income
-$13M
-56.5% margin
Net Income
-$13M
-55.4% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+16.6%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$163M
Total Liabilities
$77M
Stockholders' Equity
$86M
Cash & Equivalents
$71M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$19M
+23.3%
Gross Profit
$18M
$14M
+23.0%
Operating Income
-$13M
-$14M
+3.6%
Net Income
-$13M
-$14M
+5.1%
Geographic Segments
UNITED STATES
$16M
67%
EMEA
$6M
26%
Asia Pacific
$2M
7%
Other International Geographical Areas
$101,000
0%
← FY 2024
All Quarters
Q1 2025 →